IMM 3.13% 33.0¢ immutep limited

defensive biotechs?

  1. 2,088 Posts.
    PRR holders will be cracking a smile by Christmas :)




    http://www.theaustralian.com.au/business/opinion/no-beef-with-this-trading-halt/story-e6frg9lo-1226071973611


    THINK of a port in a market storm and biotechs don't exactly come to mind, yet some of our life- science friends posted decent gains during yesterday's 0.7 per cent market rout -- mostly for no discernible reason.

    Shares in Phylogica (PYC, 7c) led the way with a 4.5 per cent gain, while Tissue Therapies (TIS, 48.5c) gained 4.3 per cent. Others defying the trend: Bionomics (BNO, 63c), Starpharma (SPL, $1.48) and Prana Biotechnology (PBT, 18.5c).

    One theory is that spec sectors such as biotechs are hit first in a downturn and also recover first. This was the sector's experience during and after the GFC.

    With biotechs now shining,, will those gloomy brokers be cracking a smile by Christmas?

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.010(3.13%)
Mkt cap ! $479.3M
Open High Low Value Volume
32.0¢ 33.5¢ 32.0¢ $1.120M 3.427M

Buyers (Bids)

No. Vol. Price($)
25 228640 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 130861 8
View Market Depth
Last trade - 14.49pm 25/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.